These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18096420)

  • 1. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
    Bharatham K; Bharatham N; Park KH; Lee KW
    J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homology-modeled protein structure.
    Park H; Hwang KY; Oh KH; Kim YH; Lee JY; Kim K
    Bioorg Med Chem; 2008 Jan; 16(1):284-92. PubMed ID: 17920282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure modeling, ligand binding, and binding affinity calculation (LR-MM-PBSA) of human heparanase for inhibition and drug design.
    Zhou Z; Bates M; Madura JD
    Proteins; 2006 Nov; 65(3):580-92. PubMed ID: 16972282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking and SAR studies of salacinol derivatives as alpha-glucosidase inhibitors.
    Nakamura S; Takahira K; Tanabe G; Morikawa T; Sakano M; Ninomiya K; Yoshikawa M; Muraoka O; Nakanishi I
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4420-3. PubMed ID: 20598536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding mode analyses and pharmacophore model development for stilbene derivatives as a novel and competitive class of α-glucosidase inhibitors.
    Lee Y; Kim S; Kim JY; Arooj M; Kim S; Hwang S; Kim BW; Park KH; Lee KW
    PLoS One; 2014; 9(1):e85827. PubMed ID: 24465730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors.
    Bharatham N; Bharatham K; Lee KW
    J Mol Graph Model; 2007 Mar; 25(6):813-23. PubMed ID: 16996282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into human 5-lipoxygenase inhibition: combined ligand-based and target-based approach.
    Charlier C; Hénichart JP; Durant F; Wouters J
    J Med Chem; 2006 Jan; 49(1):186-95. PubMed ID: 16392803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors.
    Seo WD; Kim JH; Kang JE; Ryu HW; Curtis-Long MJ; Lee HS; Yang MS; Park KH
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5514-6. PubMed ID: 16202584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors.
    Ferreira SB; Sodero AC; Cardoso MF; Lima ES; Kaiser CR; Silva FP; Ferreira VF
    J Med Chem; 2010 Mar; 53(6):2364-75. PubMed ID: 20170190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
    Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
    J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of the alpha-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives.
    Wang S; Yan J; Wang X; Yang Z; Lin F; Zhang T
    Eur J Med Chem; 2010 Mar; 45(3):1250-5. PubMed ID: 20045223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models.
    Gopalakrishnan B; Aparna V; Jeevan J; Ravi M; Desiraju GR
    J Chem Inf Model; 2005; 45(4):1101-8. PubMed ID: 16045305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of butyl-isobutyl-phthalate and its interaction with α-glucosidase in vitro.
    Liu M; Zhang W; Qiu L; Lin X
    J Biochem; 2011 Jan; 149(1):27-33. PubMed ID: 20870646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure basis for the inhibitory mechanism of a novel DNase gamma-specific inhibitor, DR396.
    Sunaga S; Yoshimori A; Shiokawa D; Tanuma S
    Bioorg Med Chem; 2006 Jun; 14(12):4217-26. PubMed ID: 16574417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.